{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:23:58Z","timestamp":1773415438820,"version":"3.50.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jceh.2024.102421","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:30:21Z","timestamp":1728667821000},"page":"102421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccination Strategies for a Liver Transplant Recipient"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-4641","authenticated-orcid":false,"given":"Monalisa","family":"Sahu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dibyalochan","family":"Praharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeet S.","family":"Bhadoria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.102421_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jceh.2022.03.010","article-title":"Knowledge, attitude and practice of gastroenterologists and hepatologists regarding vaccination in patients with chronic liver disease","volume":"12","author":"Praharaj","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s15010-005-4094-4","article-title":"Increased incidence of fulminant hepatic failure in previously unrecognized HBsAg carriers with acute hepatitis independent of etiology","volume":"33","author":"Chu","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.jceh.2024.102421_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should Be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102421_bib4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/liv.12520","article-title":"Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study","volume":"34","author":"Gustot","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2024.102421_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases","volume":"103","author":"W\u00f6rns","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102421_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/315245","article-title":"Pneumococcal vaccine response in cirrhosis and liver transplantation","volume":"181","author":"McCashland","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CMR.16.3.357-364.2003","article-title":"Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols","volume":"16","author":"Duchini","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jceh.2024.102421_bib9","first-page":"204","article-title":"Live vaccines in pediatric liver transplant recipients: \"To Give or Not to Give\"","volume":"18","author":"Kemme","year":"2021"},{"key":"10.1016\/j.jceh.2024.102421_bib10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jceh.2024.102421_bib11","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.3748\/wjg.v28.i30.4061","article-title":"Thrombocytopenia in chronic liver disease: physiopathology and new therapeutic strategies before invasive procedures","volume":"28","author":"Gallo","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102421_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222381","article-title":"The epidemiological signature of influenza B virus and its B\/Victoria and B\/Yamagata lineages in the 21st century","volume":"14","author":"Caini","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.102421_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(10)70133-X","article-title":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study","volume":"10","author":"Kumar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.102421_bib15","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1600-6143.2011.03692.x","article-title":"Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients","volume":"11","author":"Cordero","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3851\/IMP2103","article-title":"Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine","volume":"17","author":"Siegrist","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jceh.2024.102421_bib17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A\u00a05-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031070","article-title":"Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis","volume":"9","author":"H\u00e4rm\u00e4l\u00e4","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jceh.2024.102421_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cld.898","article-title":"Optimizing vaccination in adult patients with liver disease and liver transplantation","volume":"15","author":"Rhee","year":"2020","journal-title":"Clinical liver disease"},{"key":"10.1016\/j.jceh.2024.102421_bib20","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib21","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019"},{"key":"10.1016\/j.jceh.2024.102421_bib22","article-title":"Vaccination recommendations in solid organ transplant adult candidates and recipients","volume":"11","author":"Vigan\u00f2","year":"2023"},{"key":"10.1016\/j.jceh.2024.102421_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.healun.2018.03.001","article-title":"Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis","volume":"37","author":"Mulley","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib24","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A\u00a0double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3121\/cmr.2.4.256","article-title":"Practical considerations to influenza vaccination","volume":"2","author":"Musana","year":"2004","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jceh.2024.102421_bib26","series-title":"Adverse Effects of Vaccines: Evidence and Causality","article-title":"Committee to review adverse effects of V, Institute of M","year":"2011"},{"key":"10.1016\/j.jceh.2024.102421_bib27","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1365-2222.2011.03842.x","article-title":"Influenza immunization in egg allergy: an update for the 2011-2012 season","volume":"41","author":"Erlewyn-Lajeunesse","year":"2011","journal-title":"Clin Exp Allergy: J British Soci Allergy and Clini Immunol"},{"key":"10.1016\/j.jceh.2024.102421_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2022-23 influenza season","volume":"71","author":"Grohskopf","year":"2022","journal-title":"MMWR Recommendations and reports : MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"6 Pt 1","key":"10.1016\/j.jceh.2024.102421_bib30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0091-6749(96)80191-6","article-title":"Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines","volume":"98","author":"Sakaguchi","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jceh.2024.102421_bib31","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis","volume":"33","author":"Mart\u00edn Arias","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jceh.2024.102421_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.hoc.2007.06.007","article-title":"Immune thrombocytopenic purpura","volume":"21","author":"Psaila","year":"2007","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.jceh.2024.102421_bib34","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41467-021-22637-8","article-title":"Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1","volume":"12","author":"Vuorela","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2024.102421_bib35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12098-023-04555-3","article-title":"Adverse events following immunization- the known unknowns and black box : based on 10th Dr. I. C. Verma excellence award for young pediatricians delivered as oration on 9th Oct. 2022","volume":"90","author":"Das","year":"2023","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jceh.2024.102421_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/clinids\/7.2.133","article-title":"Invasive pneumococcal infections: incidence, predisposing factors, and prognosis","volume":"7","author":"Burman","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib37","article-title":"Clinical features and outcomes of spontaneous bacterial peritonitis caused by Streptococcus pneumoniae: a matched case-control study","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2024.102421_bib38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2006.01705.x","article-title":"Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/318482","article-title":"Immunogenicity of pneumococcal vaccine in heart transplant recipients","volume":"32","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jceh.2024.102421_bib40","first-page":"27","article-title":"A\u00a0review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J\u00a0Pediatr Pharmacol Therapeut : JPPT : the official journal of PPAG"},{"key":"10.1016\/j.jceh.2024.102421_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7010013","article-title":"The role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects","volume":"7","author":"Papadatou","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.jceh.2024.102421_bib42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/hep.1840040527","article-title":"Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis","volume":"4","author":"Pirovino","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102421_bib43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-6143.2007.01668.x","article-title":"Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib44","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.21037\/jtd-22-287","article-title":"A\u00a0comprehensive overview of pneumococcal vaccination recommendations for adults in South Africa, 2022","volume":"14","author":"Feldman","year":"2022","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: updated recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jceh.2024.102421_bib46","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/j.vaccine.2016.10.020","article-title":"Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: a randomised controlled trial","volume":"34","author":"Tashani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib47","series-title":"Disclosure: David Minter Declares No Relevant Financial Relationships with Ineligible Companies","article-title":"Pneumococcal vaccine. StatPearls. Treasure island (FL) ineligible companies","author":"Tereziu","year":"2024"},{"key":"10.1016\/j.jceh.2024.102421_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199801293380503","article-title":"Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C","volume":"338","author":"Vento","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102421_bib49","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/00034983.1999.11813480","article-title":"Acute, hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV","volume":"93","author":"Pramoolsinsap","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jceh.2024.102421_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.autrev.2011.05.015","article-title":"Immunization in the adult immunocompromised host","volume":"11","author":"L\u00f6bermann","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jceh.2024.102421_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40121-019-00270-9","article-title":"Increasing burden of hepatitis A in adolescents and adults and the need for long-term protection: a review from the Indian subcontinent","volume":"8","author":"Agrawal","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jceh.2024.102421_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/lt.500060216","article-title":"Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation","volume":"6","author":"Arslan","year":"2000","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib53","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1086\/315125","article-title":"Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients","volume":"180","author":"Stark","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<215::AID-JMV16>3.0.CO;2-J","article-title":"Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease","volume":"52","author":"Lee","year":"1997","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jceh.2024.102421_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jhep.2001.25883","article-title":"Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients","volume":"34","author":"Arguedas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102421_bib56","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1572-0241.1999.01150.x","article-title":"Immunogenicity of hepatitis A vaccine in decompensated liver disease","volume":"94","author":"Dumot","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102421_bib57","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007890-200107270-00019","article-title":"Safety and efficacy of hepatitis A vaccination in liver transplantation recipients","volume":"72","author":"Arslan","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.102421_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200102150-00023","article-title":"Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients","volume":"71","author":"G\u00fcnther","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.102421_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7861\/clinmed.2020-0631","article-title":"Acute-on-chronic liver failure","volume":"20","author":"Kumar","year":"2020","journal-title":"Clin Med"},{"issue":"suppl 10A","key":"10.1016\/j.jceh.2024.102421_bib60","doi-asserted-by":"crossref","first-page":"34s","DOI":"10.1016\/j.amjmed.2005.07.012","article-title":"Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination","volume":"118","author":"Sjogren","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jceh.2024.102421_bib61","article-title":"Vaccination in liver diseases and liver Transplantation: recommendations, implications and opportunities in the post-covid era","volume":"5","author":"Ballester","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2024.102421_bib62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-Adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update","volume":"20","author":"Lee","year":"2021","journal-title":"Expet Rev Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib63","article-title":"Response to hepatitis B vaccination in patients with liver cirrhosis","volume":"27","author":"Aggeletopoulou","year":"2017"},{"key":"10.1016\/j.jceh.2024.102421_bib64","first-page":"199","article-title":"[The comparison of the humoral response among the patients with liver cirrhosis and steatosis of the liver after HBV vaccination]","volume":"60","author":"Ko\u015bli\u0144ska-Berkan","year":"2006","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.jceh.2024.102421_bib65","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S1413-86702008000400009","article-title":"Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list","volume":"12","author":"Bonazzi","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib66","first-page":"217","article-title":"Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals","volume":"50","author":"Idilman","year":"2003","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102421_bib67","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/jlts.2001.23069","article-title":"Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease","volume":"7","author":"Arslan","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib68","first-page":"848","article-title":"[Comparison of immunogenicity of vaccination and serovaccination against hepatitis B virus in patients with alcoholic cirrhosis]","volume":"21","author":"Bronowicki","year":"1997","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jceh.2024.102421_bib69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<463::AID-JMV7>3.0.CO;2-5","article-title":"Hepatitis B vaccination in patients with chronic hepatitis C","volume":"59","author":"Lee","year":"1999","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jceh.2024.102421_bib70","article-title":"Efficacy of hepatitis B virus vaccines HBVaxpro40\u00a9 and Fendrix\u00a9 in patients with chronic liver disease in clinical practice","volume":"10","author":"Horta","year":"2022"},{"key":"10.1016\/j.jceh.2024.102421_bib71","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14740338.2.3.225","article-title":"Safety of immunisation and adverse events following vaccination against hepatitis B","volume":"2","author":"Duclos","year":"2003","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.jceh.2024.102421_bib72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","article-title":"Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102421_bib73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102421_bib74","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A\u00a0phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2024.102421_bib75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib76","article-title":"Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world\u00a0cohort study using electronic health records","volume":"383","author":"Klein","year":"2023","journal-title":"BMJ"},{"issue":"suppl 4","key":"10.1016\/j.jceh.2024.102421_bib77","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1111\/j.1600-6143.2009.02901.x","article-title":"Varicella zoster virus (VZV) in solid organ transplant recipients","volume":"9","author":"Pergam","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib78","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib79","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007890-200202270-00023","article-title":"Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature","volume":"73","author":"Fehr","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.102421_bib80","first-page":"1","article-title":"Advisory committee on immunization practices, centers for disease control and prevention (CDC)","volume":"56","author":"Marin","year":"2007"},{"key":"10.1016\/j.jceh.2024.102421_bib81","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2015.01.075","article-title":"Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients","volume":"33","author":"Kawano","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib82","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/cancers14051289","article-title":"Human papillomavirus infection is associated with decreased risk of hepatocellular carcinoma in chronic hepatitis C patients: taiwan nationwide matched cohort study","volume":"14","author":"Kao","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jceh.2024.102421_bib83","first-page":"763","article-title":"Detection of human papillomavirus in primary hepatocellular carcinoma","volume":"12","author":"Scinicariello","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jceh.2024.102421_bib84","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Chin-Hong","year":"2019"},{"key":"10.1016\/j.jceh.2024.102421_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0971-5851.96961","article-title":"Cervical cancer in India and HPV vaccination","volume":"33","author":"Kaarthigeyan","year":"2012","journal-title":"Indian J Med Paediatr Oncol: Offi J Indian Soci Medical & Paediatric Oncol"},{"key":"10.1016\/j.jceh.2024.102421_bib87","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/petr.12226","article-title":"Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients","volume":"18","author":"Gomez-Lobo","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib89","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1093\/cid\/ciaa1897","article-title":"Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with human immunodeficiency virus (HIV)","volume":"73","author":"Boey","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib90","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recommendations and reports : MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jceh.2024.102421_bib91","doi-asserted-by":"crossref","first-page":"o2844","DOI":"10.1136\/bmj.o2844","article-title":"Measles is now \"an imminent threat\" globally, WHO and CDC warn","volume":"379","author":"Iacobucci","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2024.102421_bib92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00866312","article-title":"Response to measles-mumps-rubella vaccine in children on dialysis","volume":"6","author":"Schulman","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jceh.2024.102421_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3476(05)81545-8","article-title":"Measles vaccination after orthotopic liver transplantation","volume":"123","author":"Rand","year":"1993","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2024.102421_bib94","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.vaccine.2008.09.076","article-title":"Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation","volume":"26","author":"Shinjoh","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib95","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.vaccine.2014.11.052","article-title":"Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation","volume":"33","author":"Shinjoh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib96","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ajt.15101","article-title":"Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation","volume":"19","author":"Pittet","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib97","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0264-410X(99)00064-X","article-title":"Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation","volume":"17","author":"Balloni","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib98","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3476(97)70288-9","article-title":"Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant","volume":"130","author":"Ghio","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2024.102421_bib99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007890-199707270-00010","article-title":"Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients","volume":"64","author":"Enke","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.102421_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib101","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib102","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/TP.0000000000002012","article-title":"Vaccine recommendations for solid-organ transplant recipients and donors","volume":"102","author":"Stucchi","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2024.102421_bib103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1258\/td.2010.090463","article-title":"Prevalence of tuberculosis in patients with cirrhosis of liver in western India","volume":"40","author":"Baijal","year":"2010","journal-title":"Trop Doct"},{"key":"10.1016\/j.jceh.2024.102421_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S0950268899003593","article-title":"Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study","volume":"124","author":"Thulstrup","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jceh.2024.102421_bib105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jceh.2012.07.007","article-title":"A\u00a0guide to the management of tuberculosis in patients with chronic liver disease","volume":"2","author":"Dhiman","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib106","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.31649","article-title":"Cirrhosis and severe acute respiratory syndrome coronavirus 2 infection in US veterans: risk of infection, hospitalization, ventilation, and mortality","volume":"74","author":"Ioannou","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102421_bib107","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","article-title":"Inflammasome activation at the crux of severe COVID-19","volume":"21","author":"Vora","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jceh.2024.102421_bib108","series-title":"Pyroptosis and Cytokine Release","article-title":"SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes","author":"Junqueira","year":"2021"},{"key":"10.1016\/j.jceh.2024.102421_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/v14122778","article-title":"COVID-19 vaccination in patients with chronic liver disease","volume":"14","author":"Schinas","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jceh.2024.102421_bib110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/liv.15089","article-title":"Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients","volume":"42","author":"D'Offizi","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2024.102421_bib111","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2021.07.034","article-title":"Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: the debate is open","volume":"76","author":"Guarino","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib112","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib113","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/lt.26273","article-title":"Antibody response to severe acute respiratory syndrome-coronavirus-2 messenger RNA vaccines in liver transplant recipients","volume":"27","author":"Strauss","year":"2021","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2024.102421_bib114","article-title":"Humoral response to SARS-cov-2 vaccination in liver transplant recipients-A single-center experience","volume":"9","author":"Rashidi-Alavijeh","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2024.102421_bib115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2021.09.003","article-title":"SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients","volume":"20","author":"Ruether","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib116","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.2021.4385","article-title":"Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2024.102421_bib117","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/cid\/ciab580","article-title":"Poor antibody response after two doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in transplant recipients","volume":"74","author":"Mazzola","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.102421_bib118","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cgh.2021.12.022","article-title":"Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): a multicenter study","volume":"20","author":"Ai","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib119","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s10620-022-07641-2","article-title":"Antibody response and safety of ChAdOx1-nCOV (covishield) in patients with cirrhosis: a cross-sectional, observational study","volume":"68","author":"Singh","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2024.102421_bib120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.31751","article-title":"American association for the study of liver diseases expert panel consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease","volume":"74","author":"Fix","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102421_bib121","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib122","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cgh.2022.01.012","article-title":"Humoral response to 2-dose BNT162b2 mRNA COVID-19 vaccination in liver transplant recipients","volume":"20","author":"Guarino","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib123","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jhep.2022.02.015","article-title":"Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients","volume":"77","author":"Toniutto","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102421_bib124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA covid-19 vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102421_bib125","article-title":"Solid organ rejection following SARS-CoV-2 vaccination or COVID-19 infection","volume":"10","author":"Alhumaid","year":"2022","journal-title":"Syst Review Meta-Analysis"},{"key":"10.1016\/j.jceh.2024.102421_bib126","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.transproceed.2012.10.012","article-title":"Are liver transplant recipients protected against hepatitis A and B?","volume":"45","author":"Andersson","year":"2013","journal-title":"Transplant Proc"},{"issue":"suppl ment_2","key":"10.1016\/j.jceh.2024.102421_bib127","article-title":"Effect of smoking on long-term immunity after hepatitis B vaccine in infancy. A 20-year cohort study","volume":"33","author":"Fonzo","year":"2023","journal-title":"Eur J Publ Health"},{"key":"10.1016\/j.jceh.2024.102421_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12020163","article-title":"COVID-19 vaccination and alcohol consumption: justification of risks","volume":"12","author":"Solopov","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.jceh.2024.102421_bib129","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10620-020-06437-6","article-title":"Two-dose hepatitis B vaccine (Heplisav-B) results in better seroconversion than three-dose vaccine (Engerix-B) in chronic liver disease","volume":"66","author":"Amjad","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2024.102421_bib130","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.vaccine.2012.01.087","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324010880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324010880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:09:41Z","timestamp":1748297381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324010880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0973688324010880"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.102421","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination Strategies for a Liver Transplant Recipient","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.102421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102421"}}